Abbvie Inc - Futuregen Will Be Eligible to Receive up to an Additional $1.56 Bln in Clinical Development, Regulatory and Commercial Milestones
AbbVie公司-未來將有資格獲得多達15.6億美元的臨床開發、監管和商業里程碑獎金
Abbvie Inc - Futuregen Will Be Eligible to Receive up to an Additional $1.56 Bln in Clinical Development, Regulatory and Commercial Milestones
AbbVie公司-未來將有資格獲得多達15.6億美元的臨床開發、監管和商業里程碑獎金
譯文內容由第三人軟體翻譯。